Summary
We have studied the acute and chronic effects of an ACE inhibitor (captopril) on platelet function and the renin-angiotensin system in patients with congestive heart failure.
Plasma concentrations of angiotensin II fell significantly after a single dose of captopril (25 mg) and during long-term treatment with captopril (2 weeks, 75 mg/day). Plasma renin activity increased significantly after both the single and repeated doses.
Captopril did not affect ADP-induced platelet aggregation or concentrations. It seems unlikely that circulating angiotensin II affects ADP-induced platelet aggregation in patients with congestive heart failure.
Similar content being viewed by others
References
Poplawski A (1970) The effect of angiotensin II on the platelet aggregation induced by adenosine-diphosphate, epinephrine, and thrombin. Experientia 26: 86
Ding Y, MacIntyre DE, Kenyon CJ, Semple PF (1985) Potentiation of adrenaline-induced platelet aggregation by angiotensin II. Thromb Haemost 54: 717–720
Nara Y, Kihara M, Nabika T, Mano M, Horie R, Yamori Y (1984) Dietary effect on platelet aggregation in men with and without a family history of essential hypertension. Hypertension 6: 339–343
Gow IF, Padfield PL, Reid M, Stewart S, Edwards CRW, Williams BC (1987) High sodium intake increases platelet aggregation in normal females. J Hypertens 5: s243-s246
Ferguson RK, Turini GA, Brunner GA, Gavras H, McKinstrey DN (1977) A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet I: 775–778
Someya N, Morotomi Y, Kodama K, Kida O, Higa T, Kondo K, Tanaka K (1984) Suppressive effect of captopril on platelet aggregation in essential hypertension. J Cardiovasc Pharmacol 6: 840–843
James IM, Dickenson EJ, Burgoyne W, Jeremy JY, Barradas MA, Mikhailidis DP, Dandona P (1988) Treatment of hypertension with captopril: preservation of regional blood flow and reduced platelet aggregation. J Hum Hypertens 2: 21–25
Erdos EG (1975) Angiotensin I converting enzyme. Circ Res 36: 247–255
McGiff JC, Terragno NA, Malik KU, Lonigro AJ (1972) Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circ Res 31: 36–43
Szczeklik A, Gryglewski RJ, Nizankowski R, Musial J, Pieton R, Mruk J (1978) Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men. Pharmacol Res Commun 10: 545–556
Fitzgerald GA, Friedman LA, Miyamori I, O'Grady J, Lewis PJ (1979) A double-blind placebo-controlled crossover study of prostacyclin in man. Life Sci 25: 665–672
Schwartz MB, Hawiger J, Timmons S, Friesinger GC (1980) Platelet aggregates in ischaemic heart disease. Thromb Haemost 43: 185–188
De Boer AC, Turpie AGG, Butt RW, Johnston RV, Genton E (1982) Platelet release and thromboxane synthesis in symptomatic coronary artery disease. Circulation 66: 3270–3333
Parbtani A, Frampton G, Cameron JS (1980) Measurement of platelet release substances in glomerulonephritis: a comparison of beta-thromboglobulin (β-TG), platelet factor 4 (PF4), and serotonin assays. Thromb Res 19: 177–189
Shaw TRD, Duncan FM, Williams BC, Crichton E, Thompson SA, Davis JRE, Rademaker M, Edwards CRW (1985) Plasma free captopril concentrations during short and long-term treatment with oral captopril for heart failure. Br Heart J 54: 160–165
Gow IF, Corrie JET, Williams BC, Edwards CRW (1987) Development and validation of an improved radioimmunoassay for serotonin in platelet-rich plasma. Clin Chim Acta 162: 175–188
Born GVR (1985) Adenosine diphosphate as a mediator of platelet aggregation in vivio. Adv Exp Med Biol 192: 299–409
Haber E, Koerner T, Page LB, Kliman B, Purnode A (1969) Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin in normal human subjects. J Clin Endocrinol Metab 29: 1349–1355
Düsterdieck G, McElwee G (1971) Estimation of angiotensin II concentrations in human plasma by radioimmunoassay. Eur J Clin Invest 2: 32–38
Morton JJ, Webb DJ (1985) Measurement of plasma angiotensin II. Clin Sci 68: 483–484
Ding Y, Kenyon CJ, Semple PF (1985) Regulation of platelet receptors for angiotensin II in man. J Hypertens 3: 209–212
Kondowe GB, Kelly JG, Copeland S, Johnston GD (1987) The effect of chronic captopril therapy on platelet angiotensin II receptor density and vascular responsiveness to angiotensin II infusion. Eur J Clin Pharmacol 31: 525–530
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gow, I.F., Flapan, A.D., Morris, M. et al. A lack of effect of captopril on platelet aggregation in patients with congestive heart failure. Eur J Clin Pharmacol 41, 47–49 (1991). https://doi.org/10.1007/BF00280105
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280105